FindTrial
Sign In

A medical records based for observation for the application of free mydriasis fundus examination combined with artificial intelligence in screening diabetic retinopathy in endocrine clinic

Application of free mydriasis fundus examination combined with artificial intelligence in screening diabetic retinopathy in endocrine clinic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027916
Enrollment
Unknown
Registered
2019-12-04
Start date
2019-12-02
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

Gold Standard:mydriatic free fundus examination
Index test:artificial&#32
intelligence&#32
fundus&#32
report

Sponsors

Tianjin Forth Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In October 2018, our hospital began to run artificial intelligence and mydriatic free fundus examination, and treated type 2 diabetes patients in the endocrine diagnosis area before and after 1 year.

Exclusion criteria

Exclusion criteria: Gestational diabetes mellitus or diabetes mellitus combined with pregnancy; patients with cerebral infarction or serious mental illness, unclear consciousness; patients with infectious diseases such as active tuberculosis; patients with consciousness disorder caused by other diseases, patients who can't take care of themselves and those who don't want to join the group; patients with serious cardiopulmonary insufficiency; patients with active tuberculosis, etc Patients with infectious diseases.

Design outcomes

Primary

MeasureTime frame
Fundus screening rate;sensitivity;Specificity;—

Countries

China

Contacts

Public ContactShao Hailin

Tianjin Forth Central Hospital

411094338@qq.com+86 13072037685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026